Sinopharm's new crown vaccine has been approved for registration or emergency use in 119 countries, regions and international organizations - Xinhua English.news.cn

　　On August 15, Sinopharm Group held a media briefing to introduce the progress of its Chinese biological new crown vaccine in the field of international cooperation.

Zhu Jingjin, Secretary of the Party Committee and Vice President of Sinopharm China Biotechnology, introduced that at present, Sinopharm China Biotechnology’s new crown vaccine has been approved for registration or emergency use in 119 countries, regions and international organizations, and the vaccinated population covers 196 countries. billion doses of the new crown vaccine.

(Reporter Wen Mengxin Xie Longfei produced Liu Peng)

Responsible editor: [Sun Jingbo]